chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Very Bad nausea, Severe Vertigo, Bad Headaches, Blurred vision  I was hospitalized at Hospital for 1.5 days.  But the fields in question 21 would not allow me to enter the information when I checked Hospitalization.  I received the vaccination at the Stadium in  which was a State run POD.
It has been 10 days since the injection, the patient is experiencing erythema and itching at the injection site and is continuing to get larger from what the patient is saying.
Sore throat,  12 hours after the vaccine,very painful sore throat, still haves it.; And when they take large breaths, deep breaths,  it hurts; Last night, was horrible, they had fever and chills, and all seem to be gone this mooring; Last night, was horrible, they had  fever and chills, and  all seem  to be gone this mooring; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat,  12 hours after the vaccine,very painful sore throat, still haves it.), DYSPNOEA (And when they take large breaths, deep breaths,  it hurts), PYREXIA (Last night, was horrible, they had fever and chills, and all seem to be gone this mooring) and CHILLS (Last night, was horrible, they had  fever and chills, and  all seem  to be gone this mooring) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034f22a and 039k20a) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (allergic to aspirin) and Penicillin allergy.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Nov-2021, the patient experienced PYREXIA (Last night, was horrible, they had fever and chills, and all seem to be gone this mooring) and CHILLS (Last night, was horrible, they had  fever and chills, and  all seem  to be gone this mooring). On 12-Nov-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat,  12 hours after the vaccine,very painful sore throat, still haves it.) and DYSPNOEA (And when they take large breaths, deep breaths,  it hurts). On 12-Nov-2021, PYREXIA (Last night, was horrible, they had fever and chills, and all seem to be gone this mooring) and CHILLS (Last night, was horrible, they had  fever and chills, and  all seem  to be gone this mooring) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Sore throat,  12 hours after the vaccine,very painful sore throat, still haves it.) had not resolved and DYSPNOEA (And when they take large breaths, deep breaths,  it hurts) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment medications were not provided by the reporter.
pulmonary embolism. Felt sluggish and strange for a week and then had MRI on 3/4 and it was on MRI.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 25-NOV-2014, the patient was vaccinated with ZOSTAVAX (dose strength and was not reported) (lot # K011004 and expiry date: 07-NOV-2015) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
RASH ON ARMS BACK FACE CHEST  AND LEGS DOWN TO ANKLES. HEAD ACHES. RUNNING A TEMP FROM 95.5 TO 101.1. FEELING WEAK.
Diffuse hives on head, chest, abdomen, back, arms, hands?treated with antihistamine?Benadryl, Claritin and Zyrtec
Pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 007C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in the arm). At the time of the report, PAIN IN EXTREMITY (Pain in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Treatment information not provided   This case was linked to MOD-2021-100480 (Patient Link).
This spontaneous report was received from a registered nurse and refers to a patient of an unknown age and gender. There was no information about the patient's pertinent medical history, concurrent conditions, concomitant therapies, and drug reactions or allergies. On 16-MAR-2017, the patient was vaccinated with an expired dose of PNEUMOVAX23 lot number: L012215, expiration date: 13-JAN-2017 (strength, dose, frequency, route of administration, and anatomical location were not provided) for prophylaxis. No adverse effects were reported. Additional information has been requested.
Headache, Myalgia, Fever, Rash & Urticaria Pruritus
Patient was screened for COVID-19 Vaccine administration. Patient had no contraindications and was administered Moderna Vaccine at 10:12 am. At approximately 10:20 am patient stated he was not feeling well. Patient stated he was feeling cold. Patient was not having shortness of breath or difficulty breathing. He was sweaty and seemed to have a bit of difficulty talking. After monitoring for a few minutes, patient stated he was feeling worse and wanted emergency services. Technician called 911 and emergency services arrived within a few minutes. Prior to emergency services arriving, patient expressed he was feeling hot. As emergency services arrived, patient stated he was feeling better. Emergency services assessed patient, and patient refused to go to hospital. Both patient and fire department left pharmacy at 10:42 am.
Motor Neuron Disease; Neuropathy; Foot drop; This is a spontaneous report from a contactable physician. A 64-year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in Arm Left at the age of 64 years old on 25May2021 11:30 (Batch/Lot Number: EW0179) as dose 2, single for covid-19 immunisation. Medical history included hypothyroidism, seizure and hyperlipidaemia The patient previously took first dose of BNT162B2 on 04May2021 (lot number: ER8736) for covid-19 immunisation. Concomitant medications included levothyroxine (LEVOTHYROXINE), phenytoin (DILANTIN [PHENYTOIN]), simvastatin (SIMVASTATIN) and vitamin d3 (VITAMIN D3). On 31May2021, at 8:00, the patient experienced motor neuron disease. neuropathy and foot drop. The patient underwent physical therapy (PT) as treatment for the events. The outcome of the events was not recovered.; Sender's Comments: As per available information, the causal association between the event motor neuron disease and neuropathy and the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Information regarding Flumist (2003-2004 formula)(influenza virus vaccine, live intranasal (2003-2004 formula) nasal solution (frozen)) was received from a consumer regarding a 10 year old female pt who experienced "extreme tiredness".  At 10 years of age, the pt received a dose on 12/04/03.  The pt's concurrent illness includes ear infection.  The pt had a previous history of ear infections treated with Lorabid.  She was diagnosed with an ear infection the day she received Flumist.  Indication for Flumist (2003-2004 formula) was immunization.  Product was administered on 12/4/03.  Dose regimen was 1 dose (IN).  Concomitant therapy included Lorabid.  The pt experienced "extreme tiredness" on 12/05/03.  The mother reported that her daughter was "so tired she slept until one o'clock in the afternoon."  As of 12/50/03, the tiredness had not resolved.  No additional information was available at the date of this report.
Person reports rash to inner thighs with no associated itching. 3 days later individual reports feeling numbness at injection site that travels the length of her left arm to her fingertips with associated itching.
9:50PM Temperature 101F. Seizure. Seen at hospital on 9/23/02. Labs drawn, urine specimen, spinal tap all negative. Mom instructed to follow up with PCP and continue Tylenol for 4 hours.
Patient loss consciousness. Vaccine administered around 1240, approximately at 1250 patient pass out. Observer called for help and EMS was activated at 1250. Patient was flushed and not breathing, observer pushed EpiPen 0.3mL (Lot #0FM200 Exp: OCT2021)for 10 seconds at 1252. Patient woke up, helped arrived and was moved into private patient room. Fire was called at 1254 arrived at 1303. Vital signs taken at 1258 BP: 71/39 HR:73 O2: 100% Temp:98.7 degrees Celsius. Second Vital signs taken at 1300 BP: 86/49 HR:97 O2: 99% Temp:98.7 degrees Celsius. Patient stated before passing out symptoms of light headedness and heart racing and flushed. Patient improving symptoms, transported to the Hospital at 1307.
Initial information received on 21-Dec-2018 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an adult patient of unknown age and gender who received the pediatric vaccine DIPHTHERIA AND TETANUS TOXOIDS produced by unknown manufacturer lot number not reported via unknown route in unknown administration site on an unknown date instead of the adult dose of the Td. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It was a case of actual medication error due to inappropriate age at vaccine administration. It was not reported if the patient had any adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
Patient received vaccines on 2/2/21, 2/23/21 and 11/19/21.  He was admitted to the hospital on 1/30/22 and is still admitted as of today (2/15/22).  Patient is requiring BIPAP and there are discussion of hospice.
large local area rxn on 2nd dose of vax 10x15cm erythema;
She also reports taking Ajovy for her migraines/Starting Dupixent, asking if Covid Vaccine is a live virus; asthma; This is a spontaneous report from a Pfizer-sponsored program. A contactable Other HCP (patient) reported that: A 51-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number was EN6207 and expiration date was not reported), via an unspecified route of administration, administered in left arm on 10Mar2021 (Age at vaccination was 51 years) as single dose for COVID-19 immunization. The second dose was scheduled for 31Mar2021. Medical history included brain surgery a year ago. Concomitant medication(s) included fremanezumab taken for migraine, start and stop date were not reported. On an unspecified date in 2021 the patient experienced asthma and will be starting Dupixent injections for the treatment of her asthma next week. She was told to find out if the vaccine had a live virus in it because if it did, she would not be able to start the Dupixent treatments. The medication is being shipped to her Doctors office and will arrive Monday or Tuesday next week. Patient also states that she went the day before yesterday for her first vaccine. She was inquiring about a new injection that she was supposed to take, the Dupixent injection. She states the place that was going to deliver her injection said to be aware that Dupixent and live vaccines don't mix. She states that she just took the Covid vaccine the day before yesterday and she wants to make sure it was not a live vaccine. Patient was needing to speak to someone. She spoke to someone yesterday and they informed her that the virus was not live, but that she wanted them to speak because she was getting an injection of Dupixent and already got her 1st dose. The outcome of events was unknown.  No follow up attempts are possible. No further information is expected.
At home, patient's eyes rolled back, arms & legs shaking.  Parents brought patient to ER, approx 40 minutes after onset, and patient was still seizing with tonic/clonic seizures and was unresponsive.  HR 220, BP 115/93, RR 60, Temp 102 F.  Was given Ativan x1 and loaded with phenytoin. Transferred to PICU.
morbilliform rash to arms, legs, chest, torso 10 days after Moderna booster
on March 26, 2021 and April 11, 2022, the claimant was injured by Gardasil; orthostatic intolerance; functional neurological disorder; functional gait disorder; among other severe symptoms; Information has been received from a lawyer, regarding a case in litigation and concerning a 11-year-old female patient (pt). No information concerning the pt's medical history, concurrent conditions or concomitant medications was provided. On 26-MAR-2021 and 11-APR-2022, the pt was vaccinated respectively with first and second dose of quadrivalent human papillomavirus (HPV) (types 6,11,16,18) recomb. vaccine (GARDASIL) (exact dose, route of administration, anatomical location, lot # and expiration date were not reported for either of them) for prophylaxis (Inappropriate schedule of product administration). On these dates, the pt was "injured by quadrivalent human papillomavirus (HPV) (types 6,11,16,18) recomb. vaccine (GARDASIL) injections which caused her to develop orthostatic intolerance, functional neurological disorder, and functional gait disorder, among other severe symptoms". The outcome of the events was not provided.   The reporter considered the events of orthostatic intolerance, functional neurological disorder, functional gait disorder, and other severe symptoms to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL).
Started to get sick; rashes; pain in the injection site; swelling; irregular heartbeat; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 09Aug2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious) with onset Aug2021, outcome "unknown", described as "Started to get sick"; RASH (non-serious) with onset Aug2021, outcome "unknown", described as "rashes"; VACCINATION SITE PAIN (non-serious) with onset Aug2021, outcome "unknown", described as "pain in the injection site"; SWELLING (non-serious) with onset Aug2021, outcome "unknown", described as "swelling"; HEART RATE IRREGULAR (non-serious) with onset Aug2021, outcome "unknown", described as "irregular heartbeat".  Additional information: No medical questions were addressed by this program forwarded/ referred to medical information.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Mother relates nausea with onset 4hr or less after administration of vaccine, followed by abdominal pain, vomiting, diarrhea, this also occurred after 1st dose on 11/30/2005.
Admitted with worsening weakness, decreased appetite, vomiting, nausea. Tested positive for Covid 1/22/22. On admission, she was hypotensive and hypothermic with LA of 13. Na was 155, pot 5.8, bicarb 9, and Cr 4.81. She was volume resuscitated and started on broad spectrum abx. She was ultimately felt to have aspiration pna and completed a course of clindamycin.
Slight red bump- No itching or redness transeding. Nausea, fever and cold intolerance.
Shaking; Could not get warm; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose), for COVID-19 immunisation. The following information was reported: TREMOR (non-serious), outcome "recovered", described as "Shaking"; FEELING COLD (non-serious), outcome "recovered", described as "Could not get warm".  Additional information: The events subsided within 36 hours.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
severe debilitating back spasms; he suffered from "debilitating back spasms" due to a "movement he made. He added he also "had these spasms in the past; massive lower back pain; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via unspecified route of administration on 15Jan2021 as 1st dose, single for covid-19 immunisation. The patient medical history included spasms, in the past. The concomitant medication was not reported. The patient reported that, he got the first dose of the Pfizer BioNTech vaccine on 15Jan2021. On 26Jan2021, he had a massive lower back pain, he needs to take a metronidazole injection then went to a regular metronidazole. On 26Jan2021, he got severe debilitating back spasms due to a movement he made and went to ER/urgent care where they gave him a dexamethasone shot, methylprednisolone shot, and a 6-8 course of oral prednisone. Is not sure if he was going to finish it, he took the dose 6 and 5, but did not to the 4 yesterday. Wants to make sure it's not causing more problems to finish that. The dexamethasone he believes is long acting and the methylprednisolone may be similar to the regular prednisone. The patient was feeling better, and the muscle relaxers are helping, but he wants to be sure that these medications did not diminish the effectiveness of the vaccine. The hospital was wanting him back to work on the 05Feb2021 to get the second dose, but he wants to be sure these medicines has not affected or impacted the first dose. The outcome of the events was recovering. The patient specified that his symptoms were not related to the vaccine.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.; Sender's Comments: Considering a plausible temporal relationship and known product safety profile, a possible contributory role of suspect product BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) to the reported "severe debilitating back spasms" and "condition aggravated" cannot be excluded
Started with red area size of quarter (at site of flu injection on L deltoid) on evening of 8-27-12. On 8-28-12 Parent noted L deltoid area swollen and red over large area. 8-29-12 L deltoid reddened area with 100mm X 85mm and swollen.
PT recieved three vaccines in accordance with his readiness report. At the time of administration, the patient denied having any drug, food or latex allergies (verified with online medical systems) patient received his vaccines along with his classmates, was then instructed to standby in the clinic lobby until his entire class was completed. Time spent waiting was approximately 20-30min. Patient stated that he did not have any reactions until after 5pm. PT states had a itchy red rash covering his middle torso, upper right chest and right side of the neck. He denied any trouble breathing, any numbness or tingling to his extremities or any other abnormal feelings of being ill. Patient reported after sick call hours to the medical clinic he recieved the vaccines, and stated that the rash has gotten better but is still present. Patient was evaluated by the medical staff and the duty flight surgeon. Patient was released without limitations.
Pfizer-BioNtech COVID-19 Vaccine EUA  hives all over body
Moderna COVID-19 Vaccine EUA Possible delayed side effects to the vaccine first dose received on Feb 25.   On the evening of March 5th, felt tired and not normal.  On March 6th, developed a fever (99.4) and chills.   By that evening, had a temperature of 100.8 and muscle/joint pain.  But by the next morning, March 7th, the fever was completely gone as well as other symptoms.   CDC info suggested that side effects might appear up to 7 days after injection.  I was at or just beyond that time.
pt recvd vax; red raised area 3" at site immed following inject site;
On 09/27/2021, I woke up and felt like my eyeballs were falling out, intense pain on the right side of my head. It's ongoing. I still feel it. It's not a bad headache. I just know I am going to feel it later, like a pounding, that just has not gone away. Doctor called in some medication- Eletriptan HBR 40 mg, and something for me to sleep, as needed, Diazepam 10 mg. I have never had a migraine or headache like this. I normally take a pill and it's gone. This is a headache that is ongoing, that I have never experienced before. I have tried taking 4 Advils and 2 Tylenols and they do not touch it. It is not a regular headache that I have. Even if this is from the vaccine, I would still get the vaccine.
Reaction after the second shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Reaction after the second shot) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced VACCINATION COMPLICATION (Reaction after the second shot). At the time of the report, VACCINATION COMPLICATION (Reaction after the second shot) had resolved.            No concomitant medications were provided. No treatment medications were reported.   This case was linked to MOD-2021-370480 (Patient Link).
Approximately one inch below the injection site the skin became red, hot and inch. It was irregular shaped but basically round and about 2 inches in diameter. It lessened in redness today.
Left arm reddened, swollen on 06/20/02. Diagnosis: Cellulitis left arm. Treatment Duricef X 10 days